Providers

The playbook from the 3 organizations highlights 5 best practices for data sharing from organizations with real-world experience in value-based care arrangements.

Despite having 8 adalimumab biosimilars on the market now, patients may only see 1 or 2 available through their insurance, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.

Some of the many barriers patients with hidradenitis suppurativa (HS) face include accessing knowledgeable providers, insurance coverage of treatment, and the way the health care system is set up, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.

Patient-centered care (PCC) is a major part of a patient’s daily life that addresses their psychological needs, among other needs and preferences. Quality PCC has been recognized as important in clinical practice; however, implementation rates remain comparatively low.

Authors describe 3 patients with cancer who were given interleukin-23 (IL-23) inhibitors for psoriasis or immune-related psoriasis.

Some of the results with biologics and Janus kinase (JAK) inhibitors for atopic dermatitis have been better in practice compared with clinical trials, said Emma Guttman-Yassky, MD, PhD, FAAD, of the Icahn School of Medicine at Mount Sinai.

As Humira biosimilars enter the market, patient education about biosimilars is crucial to prevent the nocebo effect when patients switch from the reference product, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.

Authors defined any patient 50 years or younger as a “young” patient.

An online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.

Fabian Lang, MD, of Goethe University Hospital in Frankfurt, Germany, discussed the importance of good communication between health care providers and patients with chronic myeloid leukemia (CML).

Despite the need for improved eczema therapies and a rapid increase in available clinical trials, participation remains low.

More attention should be paid to prevent acne scarring and address the psychosocial consequences associated with it, authors argue.

Data included in this analysis are from the Respiratory Health in Northern Europe study, and they include asthma status, asthma-like symptoms, and other respiratory symptoms.

Investigators found no significant impact on survival, however.

Although previous research has explored and documented the prevalence of stigma facing people with chronic skin conditions, less is known about how patients respond to such stigma.

Researchers found that health care professionals who refer patients with chronic obstructive pulmonary disease (COPD) to pulmonary rehabilitation have a negative bias toward smoking and a positive bias toward exercising, which could affect how they present rehabilitation options.

Early detection of focal epilepsy may reduce the amount of motor vehicle accidents caused by seizures while driving.

The Act4Biosimilars Action Plan seeks to increase biosimilar adoption by at least 30 percentage points in 30-plus countries by 2030.

Patients often relapse after discharge from acute care because of long waits for outpatient treatment, lack of specialized therapists, out-of-pocket costs, and inadequate social support.

Researchers laid out 6 position statements for the technology in this patient population.

Future myasthenia gravis therapies have different mechanisms of action than current treatments, said James F. Howard Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill.

Ethical analysis of population health management calls for a communitarian vs individual approach, starting with reconceiving “covered lives” as “patient communities.”

The case report highlights the importance of considering diffuse large B-cell lymphoma (DLBCL) when evaluating patients with persistent periaortic fluid collections.

Past research shows no meaningfully increased risk of venous thromboembolism (VTE) in patients with more common chronic inflammatory skin diseases.

Misdiagnosis was common in these patients, and mean time to diagnosis was around 5 years.